Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis

Drug and Alcohol Review

Volumn 36, Issue 3, 2017, Pages 378-388

  Moberg, Christine A ^a,b   Humphreys, Keith ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

eligibility; exclusion criterion; external validity; generalisability; substance use

Indexed keywords

ALCOHOLISM; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; HUMAN; MEDICAL RESEARCH; PATIENT SELECTION; PROCEDURES; STANDARDS; TOBACCO DEPENDENCE;

ALCOHOLISM; BIOMEDICAL RESEARCH; HUMANS; PATIENT SELECTION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TOBACCO USE DISORDER;

EID: 84994193691     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12438     Document Type: Review

References (31)

1. Van Spall HGC, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals. JAMA 2007;297:1233–40.
2. Humphreys K, Harris AHS, Weingardt KR. Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. J Stud Alcohol Drugs 2008;69:757–64.
3. Humphreys K. A review of the impact of exclusion criteria on the generalizability of schizophrenia treatment research. Clin Schizophr Relat Psychoses 2014 [Epub ahead of print]. DOI:10.3371/CSRP.KH.061314
4. Moher D, Liberati A, Teztlaff J, Altman DG, Group PRISMA. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336–41.
5. Trivedi RB, Humphreys K. Participant exclusion criteria in treatment research on neurological disorders: are unrepresentative study samples problematic? Contemp Clin Trials 2015;44:20–5.
6. Halvorson M, Humphreys K. A review of the nature and impact of exclusion criteria in depression treatment outcome research. Ann Depress Anxiety 2015;2:1058.
7. Goldstein-Piekarski AN, Williams LM, Humphreys K. A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on study clinical outcomes in anxiety disorder. Transl Psychiatry In press.
8. Humphreys K, Weisner C. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am J Psychiatry 2000;154:588–94.
9. Humphreys K, Weingardt KR, Harris AHS. Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research. Alcohol Clin Exp Res 2007;31:988–95.
10. Storbjork J. Implications of enrollment eligibility criteria in alcohol treatment outcome research: generalisability and potential bias in 1- and 6-year outcomes. Drug Alcohol Rev 2014;33:604–11.
11. Humphreys K, Weingardt KR, Horst D, Joshi AA, Finney JW. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970–98. Addiction 2005;100:1249–57.
12. Melberg H, Humphreys K. Ineligibility and refusal to participate in randomised trials of treatments for drug dependence. Drug Alcohol Rev 2010;29:193–201.
13. Leeman RF, Huffman CJ, O'Malley SS. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review. Alcohol Alcohol 2007;42:196–206.
14. Stirman SW, DeRubeis RJ, Crits-Christoph P, Brody PE. Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings. J Consult Clin Psychol 2003;71:963–72.
15. Stirman SW, DeRubeis RJ, Crits-Christoph P, Rothman A. Can the randomized controlled trial literature generalize to nonrandomized patients? J Consult Clin Psychol 2005;73:127–35.
16. Blanco C, Olfson M, Okuda M, Nunes EV, Liu S-M, Hasin DS. Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend 2008;98:123–8.
17. Hoertel N, Falissard B, Humphreys K, Gorwood P, Seigneurie A-S, Limosin F. Do clinical trials of treatment of alcohol dependence adequately enroll participants with co-occurring independent mood and anxiety disorders? An analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry 2014;75:231–7.
18. Velasquez MM, DiClemente CC, Addy RC. Generalizability of project MATCH: a comparison of clients enrolled to those not enrolled in the study at one aftercare site. Drug Alcohol Depend 2000;59:177–82.
19. Maisto SA, Conigliaro J, McNeil M, Kraemer K, Kelley ME. The relationship between eligibility criteria for participation in alcohol brief intervention trials and other alcohol and health-related variables. Am J Addict 2001;10:218–31.
20. King AC, Cao D, Southard CC, Matthews A. Racial differences in eligibility and enrollment in a smoking cessation clinical trial. Health Psychol 2011;30:40–8.
21. Le Strat Y, Rehm J, Le Foll B. How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tob Control 2011;20:338–43.
22. Robinson ML, Schroeder JR, Moolchan ET. Adolescent smokers screened for a nicotine replacement treatment trial: correlates of eligibility and enrollment. Nicotine Tob Res 2006;8:447–54.
23. Frewen AR, Baillie AJ, Montebello ME. Are cannabis users who participate in a randomized clinical trial different from other treatment seekers? J Subst Abuse Treat 2009;36:339–44.
24. Okuda M, Hasin DS, Olfson M, et al. Generalizability of clinical trials for cannabis dependence to community samples. Drug Alcohol Depend 2010;111:177–81.
25. Sofuoglu M, Dudish-Poulsen S, Nicodemus KK, Babb DA, Hatsukami DK. Characteristics of research volunteers for inpatient cocaine studies: focus on selection bias. Addict Behav 2000;25:785–90.
26. Susukida R, Crum R, Stuart E, Ebnesajjad C, Mojtabai R. Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network. Addiction 2016;111:1226–34.
27. Humphreys K. Datapoints: do participants in alcoholism treatment outcome studies resemble patients seen in everyday practice? Psychiatr Serv 2003;54:1576.
28. Humphreys K, Maisel NC, Blodgett JC, Finney JW. Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders. J Stud Alcohol Drugs 2013;74:889–93.
29. Matching alcoholism treatments to client heterogeneity: Project MATCH post treatment drinking outcomes. J Stud Alcohol 1997;58:7–29.
30. McClellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 1980;168:26–33.
31. Humphreys K. Grappling with the generalizability crisis in addiction treatment research. Addiction 2016;111:1141–2.